FDA grants final approval for Mylan's Promethazine HCl Tablets
Links shared publicly online about this topic.
- 11total visits
FDA grants final approval for Mylan's Promethazine HCl Tablets
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.
View full resource at news-medical.net
Tags: Motion Sickness Medication, Nausea and Vomiting Medication, Diet and Nutrition, Drug, Pharma, FDA, Phenergan, Pentazine
Most Recently Shared on September 9, 2011 at 1:47 pm By:
FDA grants final approval for Mylan's Promethazine HCl Tablets: Mylan Inc. today announced that its subsidiary M... http://t.co/YeLBvqa
Advertisement
